Early Antibiotics After Aspiration in ICU Patients
Key facts
- Who runs it
- UConn Health
- Where
- Farmington, United StatesSee the site
- Trial code
- Status
- Terminated
- Phase
- Phase 4
- People taking part
- 5 people enrolled
- Started
- 30 Nov 2021
- Ended
- 12 Apr 2024
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Ceftriaxone
- Amoxicillin clavulanic acid
- Cefepime
- Vancomycin
- Levofloxacin
- Record updated
- 30 December 2025
- Why it stopped
- Under-enrollment
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (15)Hide the full registry criteria
Who can take part
- Admitted to the ICU within the last 24 hours, or with a witnessed aspiration event in the last 24 hours while in the ICU
- Radiographic findings on chest x-ray or CT deemed by the treating ICU team to be consistent with aspiration (e.g. dependent infiltrates or intraluminal airway debris)
- Clinical history consistent with possible aspiration (e.g. cardiac arrest, found unconscious, or with a witnessed aspiration event)
Who cannot take part
- Already received 3 or more doses of any antibiotic since hospital presentation, unless the last dose was greater than 1 week before enrollment
- Currently participating in other trials using investigational drugs or interventions
- Requires antibiotic therapy for the treatment of other infections
- White blood cell count: ≥ 11.0
- Patient "comfort measures only" at time of screening
- Currently pregnant
- Currently a prisoner
- The consenting party (patient or their legally authorized representative) is unable to understand or read English at a fifth-grade level
- 2 or more of the following are present at the time of screening:
- Temperature ≥ 38.0C (100.4F)
- Purulent secretions
- S/F (pulse oximetry saturation to FiO2) ratio ≤ 215
Where in United States
- UConn Health / John Dempsey HospitalFarmington, United States
About the trial
What the trial wants to find out
The purpose of this study is to evaluate the use of early antibiotics in ICU patients who appear to have aspirated, to help determine whether this improves outcomes by reducing the later incidence of pneumonia and other negative consequences.
The 2 groups in the trial
- AntibioticsTreatment being tested
5 days of empiric antibiotics selected from a guideline-appropriate regimen. Alternate agents may be selected by the treating team if allergies or other patient factors mandate, but are still recommended for a 5 day course. Supportive care including oxygen and ventilation can be offered ad libitum. Options include ceftriaxone, Augmentin, cefepime, vancomycin, levofloxacin.
Treatment: Ceftriaxone, Amoxicillin clavulanic acid, Cefepime, Vancomycin, and Levofloxacin
- ControlNo study treatment, for comparison
No initial antibiotic therapy unless clinical picture changes or worsens. Supportive care including oxygen and ventilation can be offered ad libitum.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Antibiotic Prophylaxis in Critically Ill Patients After Suspected Aspiration
- Record updated
- 30 December 2025